You are here



The cardiology component includes 79 researchers, 113 research professionals, as well as 133 graduate students and postdoctoral fellows, who have distinguished themselves by their scientific productivity and their contribution to advancing knowledge. Three of these researchers in 2019 were among the world’s most influential in clinical medicine. The mission of the cardiology component is to discover in order to prevent and to cure cardiovascular diseases. These diseases affect in Canada two people out of ten in the population aged over 20 and are responsible for more than 20% of the deaths, making it the second leading cause of mortality in this country. The Institute is the most important tertiary care centre for the treatment of cardiovascular disorders in Canada and an internationally recognized leader in a number of fields (metabolic cardiology, cardiac valve diseases, imaging, etc.). The close synergy with the research makes it a model for the knowledge and technology transfer into the clinic. The researchers and the clinician scientists are working in chairs, clinical and basic research teams as well as central laboratories. They use a wide range of strategies and tools including epidemiology, molecular/cellular biology, multi-omics approaches, preclinical studies, clinical trials as well as evaluative research. The biobank of the cardiology component is one of the richest in Canada and makes available to researchers more than 36,000 samples that are used to carry out innovative projects. The scientific publications that result from the use of our biobank contribute to the advancement of knowledge and the improvement of clinical practices.


Key themes

  • Cardiac electrophysiology and treatment of arrhythmias
  • Coronary disease: pathophysiology, diagnosis and therapies
  • Metabolic cardiology: prevention, cardiometabolic risk and rehabilitation
  • Valvular heart disease: pathophysiology, diagnosis and treatment

Research chairs

  • International Research Chair in Interventional Cardiology and the Transradial Approach (Olivier F. Bertrand)
  • International Research Chair in Cardiometabolic Risk (Jean-Pierre Després)
  • Research Chair and Innovation in Cardiovascular Imaging (Eric Larose)
  • Research Chair in the Pathogenesis of Insulin Resistance and Cardiovascular Diseases (André Marette)
  • FRQS Chair on the Pathobiology of Calcific Aortic Valve Disease (Patrick Mathieu)
  • Canadian Research Chair in Genomics of Heart and Lung Diseases (Yohan Bossé)
  • Canada Research Chair in Valvular Heart Diseases (Philippe Pibarot)
  • Research Chair on the “Fondation Jacques Larivière” for the development of structural heart interventions (Josep Rodés-Cabau)

Cardiology researchers

Dr. Philippe Pibarot
Assistant Director of Cardiology Research

First Name:
Last Name:
Display every publication from this author between the year and :